Prefrontal cortical circuits in anxiety and fear: an overview

Abstract

Pathological anxiety is among the most difficult neuropsychiatric diseases to treat pharmacologically, and it represents a major societal problem. Studies have implicated structural changes within the prefrontal cortex (PFC) and functional changes in the communication of the PFC with distal brain structures in anxiety disorders. Treatments that affect the activity of the PFC, including cognitive therapies and transcranial magnetic stimulation, reverse anxiety- and fear-associated circuit abnormalities through mechanisms that remain largely unclear. While the subjective experience of a rodent cannot be precisely determined, rodent models hold great promise in dissecting well-conserved circuits. Newly developed genetic and viral tools and optogenetic and chemogenetic techniques have revealed the intricacies of neural circuits underlying anxiety and fear by allowing direct examination of hypotheses drawn from existing psychological concepts. This review focuses on studies that have used these circuit-based approaches to gain a more detailed, more comprehensive, and more integrated view on how the PFC governs anxiety and fear and orchestrates adaptive defensive behaviors to hopefully provide a roadmap for the future development of therapies for pathological anxiety.

Keywords

prefrontal cortex / anxiety / fear / neural circuits / optogenetics / DREADD

References

[1] Grupe DW, Nitschke JB. Uncertainty and anticipation in anxiety: an integrated neurobiological and psychological perspective. Nat Rev Neurosci 2013; 14( 7): 488– 501

[2] Davis M, Walker DL, Miles L, Grillon C. Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology 2010; 35( 1): 105– 135

[3] Kessler RC, Petukhova M, Sampson NA, Zaslavsky AM, Wittchen HU. Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int J Methods Psychiatr Res 2012; 21( 3): 169– 184

[4] Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jönsson B, Olesen J, Allgulander C, Alonso J, Faravelli C, Fratiglioni L, Jennum P, Lieb R, Maercker A, van Os J, Preisig M, Salvador-Carulla L, Simon R, Steinhausen HC. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 2011; 21( 9): 655– 679

[5] Chisholm D, Sweeny K, Sheehan P, Rasmussen B, Smit F, Cuijpers P, Saxena S. Scaling-up treatment of depression and anxiety: a global return on investment analysis. Lancet Psychiatry 2016; 3( 5): 415– 424

[6] Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62( 6): 617– 627

[7] Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62( 6): 593– 602

[8] Lecrubier Y. Widespread underrecognition and undertreatment of anxiety and mood disorders: results from 3 European studies. J Clin Psychiatry 2007; 68(Suppl 2): 36–41

[9] Bandelow B, Michaelis S, Wedekind D. Treatment of anxiety disorders. Dialogues Clin Neurosci 2017; 19( 2): 93– 107

[10] Bandelow B, Reitt M, Röver C, Michaelis S, Görlich Y, Wedekind D. Efficacy of treatments for anxiety disorders: a meta-analysis. Int Clin Psychopharmacol 2015; 30( 4): 183– 192

[11] Kaczkurkin AN, Foa EB. Cognitive-behavioral therapy for anxiety disorders: an update on the empirical evidence. Dialogues Clin Neurosci 2015; 17( 3): 337– 346

[12] Wang Z, Whiteside SPH, Sim L, Farah W, Morrow AS, Alsawas M, Barrionuevo P, Tello M, Asi N, Beuschel B, Daraz L, Almasri J, Zaiem F, Larrea-Mantilla L, Ponce OJ, LeBlanc A, Prokop LJ, Murad MH. Comparative effectiveness and safety of cognitive behavioral therapy and pharmacotherapy for childhood anxiety disorders: a systematic review and meta-analysis. JAMA Pediatr 2017; 171( 11): 1049– 1056

[13] Carpenter JK, Andrews LA, Witcraft SM, Powers MB, Smits JAJ, Hofmann SG. Cognitive behavioral therapy for anxiety and related disorders: a meta-analysis of randomized placebo-controlled trials. Depress Anxiety 2018; 35( 6): 502– 514

[14] Zugliani MM, Cabo MC, Nardi AE, Perna G, Freire RC. Pharmacological and neuromodulatory treatments for panic disorder: clinical trials from 2010 to 2018. Psychiatry Investig 2019; 16( 1): 50– 58

[15] Freire RC, Cabrera-Abreu C, Milev R. Neurostimulation in anxiety disorders, post-traumatic stress disorder, and obsessive-compulsive disorder. Adv Exp Med Biol 2020; 1191 : 331– 346

[16] Deppermann S, Vennewald N, Diemer J, Sickinger S, Haeussinger FB, Notzon S, Laeger I, Arolt V, Ehlis AC, Zwanzger P, Fallgatter AJ. Does rTMS alter neurocognitive functioning in patients with panic disorder/agoraphobia? An fNIRS-based investigation of prefrontal activation during a cognitive task and its modulation via sham-controlled rTMS. BioMed Res Int 2014; 2014 : 542526

[17] Clark DA, Beck AT. Cognitive theory and therapy of anxiety and depression: convergence with neurobiological findings. Trends Cogn Sci 2010; 14( 9): 418– 424

[18] Linden DE. How psychotherapy changes the brain—the contribution of functional neuroimaging. Mol Psychiatry 2006; 11( 6): 528– 538

[19] Raij T, Nummenmaa A, Marin MF, Porter D, Furtak S, Setsompop K, Milad MR. Prefrontal cortex stimulation enhances fear extinction memory in humans. Biol Psychiatry 2018; 84( 2): 129– 137

[20] Chocyk A, Majcher-Maślanka I, Dudys D, Przyborowska A, Wędzony K. Impact of early-life stress on the medial prefrontal cortex functions—a search for the pathomechanisms of anxiety and mood disorders. Pharmacol Rep 2013; 65( 6): 1462– 1470

[21] Myers-Schulz B, Koenigs M. Functional anatomy of ventromedial prefrontal cortex: implications for mood and anxiety disorders. Mol Psychiatry 2012; 17( 2): 132– 141

[22] Thompson-Schill SL, Jonides J, Marshuetz C, Smith EE, D’Esposito M, Kan IP, Knight RT, Swick D. Effects of frontal lobe damage on interference effects in working memory. Cogn Affect Behav Neurosci 2002; 2( 2): 109– 120

[23] Bremner JD. Traumatic stress: effects on the brain. Dialogues Clin Neurosci 2006; 8( 4): 445– 461

[24] Liberzon I, Martis B. Neuroimaging studies of emotional responses in PTSD. Ann N Y Acad Sci 2006; 1071( 1): 87– 109

[25] Shin LM, Rauch SL, Pitman RK. Amygdala, medial prefrontal cortex, and hippocampal function in PTSD. Ann N Y Acad Sci 2006; 1071( 1): 67– 79

[26] Bruce SE, Buchholz KR, Brown WJ, Yan L, Durbin A, Sheline YI. Altered emotional interference processing in the amygdala and insula in women with post-traumatic stress disorder. Neuroimage Clin 2013; 2 : 43– 49

[27] Brinkmann L, Buff C, Feldker K, Tupak SV, Becker MPI, Herrmann MJ, Straube T. Distinct phasic and sustained brain responses and connectivity of amygdala and bed nucleus of the stria terminalis during threat anticipation in panic disorder. Psychol Med 2017; 47( 15): 2675– 2688

[28] Ball TM, Sullivan S, Flagan T, Hitchcock CA, Simmons A, Paulus MP, Stein MB. Selective effects of social anxiety, anxiety sensitivity, and negative affectivity on the neural bases of emotional face processing. Neuroimage 2012; 59( 2): 1879– 1887

[29] Buff C, Schmidt C, Brinkmann L, Gathmann B, Tupak S, Straube T. Directed threat imagery in generalized anxiety disorder. Psychol Med 2018; 48( 4): 617– 628

[30] Labuschagne I, Phan KL, Wood A, Angstadt M, Chua P, Heinrichs M, Stout JC, Nathan PJ. Medial frontal hyperactivity to sad faces in generalized social anxiety disorder and modulation by oxytocin. Int J Neuropsychopharmacol 2012; 15( 7): 883– 896

[31] Wang HY, Zhang XX, Si CP, Xu Y, Liu Q, Bian HT, Zhang BW, Li XL, Yan ZR. Prefrontoparietal dysfunction during emotion regulation in anxiety disorder: a meta-analysis of functional magnetic resonance imaging studies. Neuropsychiatr Dis Treat 2018; 14 : 1183– 1198

[32] Etkin A, Wager TD. Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. Am J Psychiatry 2007; 164( 10): 1476– 1488

[33] Sylvester CM, Corbetta M, Raichle ME, Rodebaugh TL, Schlaggar BL, Sheline YI, Zorumski CF, Lenze EJ. Functional network dysfunction in anxiety and anxiety disorders. Trends Neurosci 2012; 35( 9): 527– 535

[34] Arnsten AF, Raskind MA, Taylor FB, Connor DF. The effects of stress exposure on prefrontal cortex: translating basic research into successful treatments for post-traumatic stress disorder. Neurobiol Stress 2015; 1 : 89– 99

[35] Long Z, Medlock C, Dzemidzic M, Shin YW, Goddard AW, Dydak U. Decreased GABA levels in anterior cingulate cortex/medial prefrontal cortex in panic disorder. Prog Neuropsychopharmacol Biol Psychiatry 2013; 44 : 131– 135

[36] Hasler G, Nugent AC, Carlson PJ, Carson RE, Geraci M, Drevets WC. Altered cerebral γ-aminobutyric acid type A-benzodiazepine receptor binding in panic disorder determined by [11C]flumazenil positron emission tomography. Arch Gen Psychiatry 2008; 65( 10): 1166– 1175

[37] Herrmann MJ, Katzorke A, Busch Y, Gromer D, Polak T, Pauli P, Deckert J. Medial prefrontal cortex stimulation accelerates therapy response of exposure therapy in acrophobia. Brain Stimul 2017; 10( 2): 291– 297

[38] Balconi M, Ferrari C. Left DLPFC rTMS stimulation reduced the anxiety bias effect or how to restore the positive memory processing in high-anxiety subjects. Psychiatry Res 2013; 209( 3): 554– 559

[39] Makovac E, Watson DR, Meeten F, Garfinkel SN, Cercignani M, Critchley HD, Ottaviani C. Amygdala functional connectivity as a longitudinal biomarker of symptom changes in generalized anxiety. Soc Cogn Affect Neurosci 2016; 11( 11): 1719– 1728

[40] Jung YH, Shin JE, Lee YI, Jang JH, Jo HJ, Choi SH. Altered amygdala resting-state functional connectivity and hemispheric asymmetry in patients with social anxiety disorder. Front Psychiatry 2018; 9 : 164

[41] Lipka J, Hoffmann M, Miltner WH, Straube T. Effects of cognitive-behavioral therapy on brain responses to subliminal and supraliminal threat and their functional significance in specific phobia. Biol Psychiatry 2014; 76( 11): 869– 877

[42] Goldin PR, Ziv M, Jazaieri H, Hahn K, Heimberg R, Gross JJ. Impact of cognitive behavioral therapy for social anxiety disorder on the neural dynamics of cognitive reappraisal of negative self-beliefs: randomized clinical trial. JAMA Psychiatry 2013; 70( 10): 1048– 1056

[43] Andreescu C, Sheu LK, Tudorascu D, Gross JJ, Walker S, Banihashemi L, Aizenstein H. Emotion reactivity and regulation in late-life generalized anxiety disorder: functional connectivity at baseline and post-treatment. Am J Geriatr Psychiatry 2015; 23( 2): 200– 214

[44] Belzung C, Griebel G. Measuring normal and pathological anxiety-like behaviour in mice: a review. Behav Brain Res 2001; 125( 1-2): 141– 149

[45] Cryan JF, Holmes A. The ascent of mouse: advances in modelling human depression and anxiety. Nat Rev Drug Discov 2005; 4( 9): 775– 790

[46] Anderson DJ, Adolphs R. A framework for studying emotions across species. Cell 2014; 157( 1): 187– 200

[47] Pellow S, Chopin P, File SE, Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 1985; 14( 3): 149– 167

[48] Kraeuter AK, Guest PC, Sarnyai Z. The open field test for measuring locomotor activity and anxiety-like behavior. Methods Mol Biol 2019; 1916 : 99– 103

[49] Ambrogi Lorenzini C, Bucherelli C, Giachetti A. Passive and active avoidance behavior in the light-dark box test. Physiol Behav 1984; 32( 4): 687– 689

[50] Dulawa SC, Holick KA, Gundersen B, Hen R. Effects of chronic fluoxetine in animal models of anxiety and depression. Neuropsychopharmacology 2004; 29( 7): 1321– 1330

[51] Merali Z, Levac C, Anisman H. Validation of a simple, ethologically relevant paradigm for assessing anxiety in mice. Biol Psychiatry 2003; 54( 5): 552– 565

[52] Shang C, Liu Z, Chen Z, Shi Y, Wang Q, Liu S, Li D, Cao P. A parvalbumin-positive excitatory visual pathway to trigger fear responses in mice. Science 2015; 348( 6242): 1472– 1477

[53] Yang H, Yang J, Xi W, Hao S, Luo B, He X, Zhu L, Lou H, Yu YQ, Xu F, Duan S, Wang H. Laterodorsal tegmentum interneuron subtypes oppositely regulate olfactory cue-induced innate fear. Nat Neurosci 2016; 19( 2): 283– 289

[54] Myers KM, Davis M. Mechanisms of fear extinction. Mol Psychiatry 2007; 12( 2): 120– 150

[55] Tovote P, Fadok JP, Lüthi A. Neuronal circuits for fear and anxiety. Nat Rev Neurosci 2015; 16( 6): 317– 331

[56] Graham BM, Milad MR. The study of fear extinction: implications for anxiety disorders. Am J Psychiatry 2011; 168( 12): 1255– 1265

[57] Bremner JD, Elzinga B, Schmahl C, Vermetten E. Structural and functional plasticity of the human brain in posttraumatic stress disorder. Prog Brain Res 2007; 167 : 171– 186

[58] Duvarci S, Pare D. Amygdala microcircuits controlling learned fear. Neuron 2014; 82( 5): 966– 980

[59] Calhoon GG, Tye KM. Resolving the neural circuits of anxiety. Nat Neurosci 2015; 18( 10): 1394– 1404

[60] Deisseroth K. Optogenetics: 10 years of microbial opsins in neuroscience. Nat Neurosci 2015; 18( 9): 1213– 1225

[61] Yizhar O, Fenno LE, Davidson TJ, Mogri M, Deisseroth K. Optogenetics in neural systems. Neuron 2011; 71( 1): 9– 34

[62] Sternson SM, Roth BL. Chemogenetic tools to interrogate brain functions. Annu Rev Neurosci 2014; 37( 1): 387– 407

[63] Armbruster BN, Li X, Pausch MH, Herlitze S, Roth BL. Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand. Proc Natl Acad Sci USA 2007; 104( 12): 5163– 5168

[64] Urban DJ, Roth BL. DREADDs (designer receptors exclusively activated by designer drugs): chemogenetic tools with therapeutic utility. Annu Rev Pharmacol Toxicol 2015; 55( 1): 399– 417

[65] Gomez JL, Bonaventura J, Lesniak W, Mathews WB, Sysa-Shah P, Rodriguez LA, Ellis RJ, Richie CT, Harvey BK, Dannals RF, Pomper MG, Bonci A, Michaelides M. Chemogenetics revealed: DREADD occupancy and activation via converted clozapine. Science 2017; 357( 6350): 503– 507

[66] Kremer EJ, Boutin S, Chillon M, Danos O. Canine adenovirus vectors: an alternative for adenovirus-mediated gene transfer. J Virol 2000; 74( 1): 505– 512

[67] Nectow AR, Nestler EJ. Viral tools for neuroscience. Nat Rev Neurosci 2020; 21( 12): 669– 681

[68] Zimmermann D, Zhou A, Kiesel M, Feldbauer K, Terpitz U, Haase W, Schneider-Hohendorf T, Bamberg E, Sukhorukov VL. Effects on capacitance by overexpression of membrane proteins. Biochem Biophys Res Commun 2008; 369( 4): 1022– 1026

[69] Moser E, Mathiesen I, Andersen P. Association between brain temperature and dentate field potentials in exploring and swimming rats. Science 1993; 259( 5099): 1324– 1326

[70] Long MA, Fee MS. Using temperature to analyse temporal dynamics in the songbird motor pathway. Nature 2008; 456( 7219): 189– 194

[71] Mahn M, Prigge M, Ron S, Levy R, Yizhar O. Biophysical constraints of optogenetic inhibition at presynaptic terminals. Nat Neurosci 2016; 19( 4): 554– 556

[72] Stachniak TJ, Ghosh A, Sternson SM. Chemogenetic synaptic silencing of neural circuits localizes a hypothalamus→midbrain pathway for feeding behavior. Neuron 2014; 82( 4): 797– 808

[73] Vardy E, Robinson JE, Li C, Olsen RHJ, DiBerto JF, Giguere PM, Sassano FM, Huang XP, Zhu H, Urban DJ, White KL, Rittiner JE, Crowley NA, Pleil KE, Mazzone CM, Mosier PD, Song J, Kash TL, Malanga CJ, Krashes MJ, Roth BL. A new DREADD facilitates the multiplexed chemogenetic interrogation of behavior. Neuron 2015; 86( 4): 936– 946

[74] Preuss TM, Wise SP. Evolution of prefrontal cortex. Neuropsychopharmacology 2022; 47( 1): 3– 19

[75] Schaeffer DJ, Hori Y, Gilbert KM, Gati JS, Menon RS, Everling S. Divergence of rodent and primate medial frontal cortex functional connectivity. Proc Natl Acad Sci USA 2020; 117( 35): 21681– 21689

[76] Roberts AC. Prefrontal regulation of threat-elicited behaviors: a pathway to translation. Annu Rev Psychol 2020; 71( 1): 357– 387

[77] Heidbreder CA, Groenewegen HJ. The medial prefrontal cortex in the rat: evidence for a dorso-ventral distinction based upon functional and anatomical characteristics. Neurosci Biobehav Rev 2003; 27( 6): 555– 579

[78] Warthen DM, Lambeth PS, Ottolini M, Shi Y, Barker BS, Gaykema RP, Newmyer BA, Joy-Gaba J, Ohmura Y, Perez-Reyes E, Güler AD, Patel MK, Scott MM. Activation of pyramidal neurons in mouse medial prefrontal cortex enhances food-seeking behavior while reducing impulsivity in the absence of an effect on food intake. Front Behav Neurosci 2016; 10 : 63

[79] Covington HE 3rd, Lobo MK, Maze I, Vialou V, Hyman JM, Zaman S, LaPlant Q, Mouzon E, Ghose S, Tamminga CA, Neve RL, Deisseroth K, Nestler EJ. Antidepressant effect of optogenetic stimulation of the medial prefrontal cortex. J Neurosci 2010; 30( 48): 16082– 16090

[80] Chen YH, Wu JL, Hu NY, Zhuang JP, Li WP, Zhang SR, Li XW, Yang JM, Gao TM. Distinct projections from the infralimbic cortex exert opposing effects in modulating anxiety and fear. J Clin Invest 2021; 131( 14): e145692

[81] Wang GQ, Cen C, Li C, Cao S, Wang N, Zhou Z, Liu XM, Xu Y, Tian NX, Zhang Y, Wang J, Wang LP, Wang Y. Deactivation of excitatory neurons in the prelimbic cortex via Cdk5 promotes pain sensation and anxiety. Nat Commun 2015; 6( 1): 7660

[82] Adhikari A, Lerner TN, Finkelstein J, Pak S, Jennings JH, Davidson TJ, Ferenczi E, Gunaydin LA, Mirzabekov JJ, Ye L, Kim SY, Lei A, Deisseroth K. Basomedial amygdala mediates top-down control of anxiety and fear. Nature 2015; 527( 7577): 179– 185

[83] Hare BD, Shinohara R, Liu RJ, Pothula S, DiLeone RJ, Duman RS. Optogenetic stimulation of medial prefrontal cortex Drd1 neurons produces rapid and long-lasting antidepressant effects. Nat Commun 2019; 10( 1): 223

[84] Gee S, Ellwood I, Patel T, Luongo F, Deisseroth K, Sohal VS. Synaptic activity unmasks dopamine D2 receptor modulation of a specific class of layer V pyramidal neurons in prefrontal cortex. J Neurosci 2012; 32( 14): 4959– 4971

[85] Fuchikami M, Thomas A, Liu R, Wohleb ES, Land BB, DiLeone RJ, Aghajanian GK, Duman RS. Optogenetic stimulation of infralimbic PFC reproduces ketamine’s rapid and sustained antidepressant actions. Proc Natl Acad Sci USA 2015; 112( 26): 8106– 8111

[86] Vogt BA, Paxinos G. Cytoarchitecture of mouse and rat cingulate cortex with human homologies. Brain Struct Funct 2014; 219( 1): 185– 192

[87] Heilbronner SR, Rodriguez-Romaguera J, Quirk GJ, Groenewegen HJ, Haber SN. Circuit-based corticostriatal homologies between rat and primate. Biol Psychiatry 2016; 80( 7): 509– 521

[88] Alexander L, Wood CM, Gaskin PLR, Sawiak SJ, Fryer TD, Hong YT, McIver L, Clarke HF, Roberts AC. Over-activation of primate subgenual cingulate cortex enhances the cardiovascular, behavioral and neural responses to threat. Nat Commun 2020; 11( 1): 5386

[89] Jhang J, Lee H, Kang MS, Lee HS, Park H, Han JH. Anterior cingulate cortex and its input to the basolateral amygdala control innate fear response. Nat Commun 2018; 9( 1): 2744

[90] Falconi-Sobrinho LL, Dos Anjos-Garcia T, Coimbra NC. Nitric oxide-mediated defensive and antinociceptive responses organised at the anterior hypothalamus of mice are modulated by glutamatergic inputs from area 24b of the cingulate cortex. J Psychopharmacol 2021; 35( 1): 78– 90

[91] Falconi-Sobrinho LL Dos Anjos-Garcia T Elias-Filho DH Coimbra NC. Unravelling cortico-hypothalamic pathways regulating unconditioned fear-induced antinociception and defensive behaviours. Neuropharmacology 2017; 113(Pt A): 367–385 doi:10.1016/j.neuropharm.2016.10.001

[92] Falconi-Sobrinho LL, Dos Anjos-Garcia T, de Oliveira R, Coimbra NC. Decrease in NMDA receptor-signalling activity in the anterior cingulate cortex diminishes defensive behaviour and unconditioned fear-induced antinociception elicited by GABAergic tonic inhibition impairment in the posterior hypothalamus. Eur Neuropsychopharmacol 2017; 27( 11): 1120– 1131

[93] Page CE, Shepard R, Heslin K, Coutellier L. Prefrontal parvalbumin cells are sensitive to stress and mediate anxiety-related behaviors in female mice. Sci Rep 2019; 9( 1): 19772

[94] Soumier A, Sibille E. Opposing effects of acute versus chronic blockade of frontal cortex somatostatin-positive inhibitory neurons on behavioral emotionality in mice. Neuropsychopharmacology 2014; 39( 9): 2252– 2262

[95] Tromp DP, Grupe DW, Oathes DJ, McFarlin DR, Hernandez PJ, Kral TR, Lee JE, Adams M, Alexander AL, Nitschke JB. Reduced structural connectivity of a major frontolimbic pathway in generalized anxiety disorder. Arch Gen Psychiatry 2012; 69( 9): 925– 934

[96] Prater KE, Hosanagar A, Klumpp H, Angstadt M, Phan KL. Aberrant amygdala-frontal cortex connectivity during perception of fearful faces and at rest in generalized social anxiety disorder. Depress Anxiety 2013; 30( 3): 234– 241

[97] Rosenkranz JA, Grace AA. Dopamine attenuates prefrontal cortical suppression of sensory inputs to the basolateral amygdala of rats. J Neurosci 2001; 21( 11): 4090– 4103

[98] Motzkin JC, Philippi CL, Wolf RC, Baskaya MK, Koenigs M. Ventromedial prefrontal cortex is critical for the regulation of amygdala activity in humans. Biol Psychiatry 2015; 77( 3): 276– 284

[99] Quirk GJ, Likhtik E, Pelletier JG, Paré D. Stimulation of medial prefrontal cortex decreases the responsiveness of central amygdala output neurons. J Neurosci 2003; 23( 25): 8800– 8807

[100] Rosenkranz JA, Moore H, Grace AA. The prefrontal cortex regulates lateral amygdala neuronal plasticity and responses to previously conditioned stimuli. J Neurosci 2003; 23( 35): 11054– 11064

[101] Adhikari A, Topiwala MA, Gordon JA. Single units in the medial prefrontal cortex with anxiety-related firing patterns are preferentially influenced by ventral hippocampal activity. Neuron 2011; 71( 5): 898– 910

[102] Adhikari A, Topiwala MA, Gordon JA. Synchronized activity between the ventral hippocampus and the medial prefrontal cortex during anxiety. Neuron 2010; 65( 2): 257– 269

[103] Zhang WH, Zhang JY, Holmes A, Pan BX. Amygdala circuit substrates for stress adaptation and adversity. Biol Psychiatry 2021; 89( 9): 847– 856

[104] Liu WZ, Zhang WH, Zheng ZH, Zou JX, Liu XX, Huang SH, You WJ, He Y, Zhang JY, Wang XD, Pan BX. Identification of a prefrontal cortex-to-amygdala pathway for chronic stress-induced anxiety. Nat Commun 2020; 11( 1): 2221

[105] Parfitt GM, Nguyen R, Bang JY, Aqrabawi AJ, Tran MM, Seo DK, Richards BA, Kim JC. Bidirectional control of anxiety-related behaviors in mice: role of inputs arising from the ventral hippocampus to the lateral septum and medial prefrontal cortex. Neuropsychopharmacology 2017; 42( 8): 1715– 1728

[106] Padilla-Coreano N, Bolkan SS, Pierce GM, Blackman DR, Hardin WD, Garcia-Garcia AL, Spellman TJ, Gordon JA. Direct ventral hippocampal-prefrontal input is required for anxiety-related neural activity and behavior. Neuron 2016; 89( 4): 857– 866

[107] Kepecs A, Fishell G. Interneuron cell types are fit to function. Nature 2014; 505( 7483): 318– 326

[108] Hattori R, Kuchibhotla KV, Froemke RC, Komiyama T. Functions and dysfunctions of neocortical inhibitory neuron subtypes. Nat Neurosci 2017; 20( 9): 1199– 1208

[109] Wamsley B, Fishell G. Genetic and activity-dependent mechanisms underlying interneuron diversity. Nat Rev Neurosci 2017; 18( 5): 299– 309

[110] Seybold BA, Stanco A, Cho KK, Potter GB, Kim C, Sohal VS, Rubenstein JL, Schreiner CE. Chronic reduction in inhibition reduces receptive field size in mouse auditory cortex. Proc Natl Acad Sci USA 2012; 109( 34): 13829– 13834

[111] Felix-Ortiz AC, Burgos-Robles A, Bhagat ND, Leppla CA, Tye KM. Bidirectional modulation of anxiety-related and social behaviors by amygdala projections to the medial prefrontal cortex. Neuroscience 2016; 321 : 197– 209

[112] Do-Monte FH, Quiñones-Laracuente K, Quirk GJ. A temporal shift in the circuits mediating retrieval of fear memory. Nature 2015; 519( 7544): 460– 463

[113] Wallis CU, Cardinal RN, Alexander L, Roberts AC, Clarke HF. Opposing roles of primate areas 25 and 32 and their putative rodent homologs in the regulation of negative emotion. Proc Natl Acad Sci USA 2017; 114( 20): E4075– E4084

[114] Kim HS, Cho HY, Augustine GJ, Han JH. Selective control of fear expression by optogenetic manipulation of infralimbic cortex after extinction. Neuropsychopharmacology 2016; 41( 5): 1261– 1273

[115] DeNardo LA, Liu CD, Allen WE, Adams EL, Friedmann D, Fu L, Guenthner CJ, Tessier-Lavigne M, Luo L. Temporal evolution of cortical ensembles promoting remote memory retrieval. Nat Neurosci 2019; 22( 3): 460– 469

[116] Ramanathan KR, Jin J, Giustino TF, Payne MR, Maren S. Prefrontal projections to the thalamic nucleus reuniens mediate fear extinction. Nat Commun 2018; 9( 1): 4527

[117] Bloodgood DW, Sugam JA, Holmes A, Kash TL. Fear extinction requires infralimbic cortex projections to the basolateral amygdala. Transl Psychiatry 2018; 8( 1): 60

[118] Do-Monte FH, Manzano-Nieves G, Quiñones-Laracuente K, Ramos-Medina L, Quirk GJ. Revisiting the role of infralimbic cortex in fear extinction with optogenetics. J Neurosci 2015; 35( 8): 3607– 3615

[119] Milad MR, Quirk GJ. Neurons in medial prefrontal cortex signal memory for fear extinction. Nature 2002; 420( 6911): 70– 74

[120] Milad MR, Quirk GJ. Fear extinction as a model for translational neuroscience: ten years of progress. Annu Rev Psychol 2012; 63( 1): 129– 151

[121] Milad MR, Rauch SL, Pitman RK, Quirk GJ. Fear extinction in rats: implications for human brain imaging and anxiety disorders. Biol Psychol 2006; 73( 1): 61– 71

[122] Milad MR, Wright CI, Orr SP, Pitman RK, Quirk GJ, Rauch SL. Recall of fear extinction in humans activates the ventromedial prefrontal cortex and hippocampus in concert. Biol Psychiatry 2007; 62( 5): 446– 454

[123] Phelps EA, Delgado MR, Nearing KI, LeDoux JE. Extinction learning in humans: role of the amygdala and vmPFC. Neuron 2004; 43( 6): 897– 905

[124] Chang CH, Maren S. Strain difference in the effect of infralimbic cortex lesions on fear extinction in rats. Behav Neurosci 2010; 124( 3): 391– 397

[125] Rajasethupathy P, Sankaran S, Marshel JH, Kim CK, Ferenczi E, Lee SY, Berndt A, Ramakrishnan C, Jaffe A, Lo M, Liston C, Deisseroth K. Projections from neocortex mediate top-down control of memory retrieval. Nature 2015; 526( 7575): 653– 659

[126] Marek R, Xu L, Sullivan RKP, Sah P. Excitatory connections between the prelimbic and infralimbic medial prefrontal cortex show a role for the prelimbic cortex in fear extinction. Nat Neurosci 2018; 21( 5): 654– 658

[127] Cummings KA, Clem RL. Prefrontal somatostatin interneurons encode fear memory. Nat Neurosci 2020; 23( 1): 61– 74

[128] Mukherjee A, Caroni P. Infralimbic cortex is required for learning alternatives to prelimbic promoted associations through reciprocal connectivity. Nat Commun 2018; 9( 1): 2727

[129] Chen YH, Hu NY, Wu DY, Bi LL, Luo ZY, Huang L, Wu JL, Wang ML, Li JT, Song YL, Zhang SR, Jie W, Li XW, Zhang SZ, Yang JM, Gao TM. PV network plasticity mediated by neuregulin1-ErbB4 signalling controls fear extinction. Mol Psychiatry 2022; 27( 2): 896– 906

[130] Karalis N, Dejean C, Chaudun F, Khoder S, Rozeske RR, Wurtz H, Bagur S, Benchenane K, Sirota A, Courtin J, Herry C. 4-Hz oscillations synchronize prefrontal-amygdala circuits during fear behavior. Nat Neurosci 2016; 19( 4): 605– 612

[131] Courtin J, Chaudun F, Rozeske RR, Karalis N, Gonzalez-Campo C, Wurtz H, Abdi A, Baufreton J, Bienvenu TC, Herry C. Prefrontal parvalbumin interneurons shape neuronal activity to drive fear expression. Nature 2014; 505( 7481): 92– 96

[132] Bukalo O, Pinard CR, Silverstein S, Brehm C, Hartley ND, Whittle N, Colacicco G, Busch E, Patel S, Singewald N, Holmes A. Prefrontal inputs to the amygdala instruct fear extinction memory formation. Sci Adv 2015; 1( 6): e1500251

[133] Xu W, Südhof TC. A neural circuit for memory specificity and generalization. Science 2013; 339( 6125): 1290– 1295

[134] Davoodi FG, Motamedi F, Akbari E, Ghanbarian E, Jila B. Effect of reversible inactivation of reuniens nucleus on memory processing in passive avoidance task. Behav Brain Res 2011; 221( 1): 1– 6

[135] Ito HT, Zhang SJ, Witter MP, Moser EI, Moser MB. A prefrontal-thalamo-hippocampal circuit for goal-directed spatial navigation. Nature 2015; 522( 7554): 50– 55

[136] Vertes RP, Hoover WB, Szigeti-Buck K, Leranth C. Nucleus reuniens of the midline thalamus: link between the medial prefrontal cortex and the hippocampus. Brain Res Bull 2007; 71( 6): 601– 609

[137] Griffin AL. Role of the thalamic nucleus reuniens in mediating interactions between the hippocampus and medial prefrontal cortex during spatial working memory. Front Syst Neurosci 2015; 9 : 29

[138] Hoover WB, Vertes RP. Anatomical analysis of afferent projections to the medial prefrontal cortex in the rat. Brain Struct Funct 2007; 212( 2): 149– 179

[139] Ji G, Neugebauer V. Modulation of medial prefrontal cortical activity using in vivo recordings and optogenetics. Mol Brain 2012; 5( 1): 36

[140] van Aerde KI, Heistek TS, Mansvelder HD. Prelimbic and infralimbic prefrontal cortex interact during fast network oscillations. PLoS One 2008; 3( 7): e2725

[141] Senn V, Wolff SB, Herry C, Grenier F, Ehrlich I, Gründemann J, Fadok JP, Müller C, Letzkus JJ, Lüthi A. Long-range connectivity defines behavioral specificity of amygdala neurons. Neuron 2014; 81( 2): 428– 437

[142] Klavir O, Prigge M, Sarel A, Paz R, Yizhar O. Manipulating fear associations via optogenetic modulation of amygdala inputs to prefrontal cortex. Nat Neurosci 2017; 20( 6): 836– 844

[143] Parent MA, Wang L, Su J, Netoff T, Yuan LL. Identification of the hippocampal input to medial prefrontal cortex in vitro. Cereb Cortex 2010; 20( 2): 393– 403

[144] Marek R, Jin J, Goode TD, Giustino TF, Wang Q, Acca GM, Holehonnur R, Ploski JE, Fitzgerald PJ, Lynagh T, Lynch JW, Maren S, Sah P. Hippocampus-driven feed-forward inhibition of the prefrontal cortex mediates relapse of extinguished fear. Nat Neurosci 2018; 21( 3): 384– 392

[145] Pi HJ, Hangya B, Kvitsiani D, Sanders JI, Huang ZJ, Kepecs A. Cortical interneurons that specialize in disinhibitory control. Nature 2013; 503( 7477): 521– 524

[146] Froemke RC, Merzenich MM, Schreiner CE. A synaptic memory trace for cortical receptive field plasticity. Nature 2007; 450( 7168): 425– 429

[147] Royer S, Zemelman BV, Losonczy A, Kim J, Chance F, Magee JC, Buzsáki G. Control of timing, rate and bursts of hippocampal place cells by dendritic and somatic inhibition. Nat Neurosci 2012; 15( 5): 769– 775

[148] Butler AC, Chapman JE, Forman EM, Beck AT. The empirical status of cognitive-behavioral therapy: a review of meta-analyses. Clin Psychol Rev 2006; 26( 1): 17– 31

[149] Sun Q, Li X, Ren M, Zhao M, Zhong Q, Ren Y, Luo P, Ni H, Zhang X, Zhang C, Yuan J, Li A, Luo M, Gong H, Luo Q. A whole-brain map of long-range inputs to GABAergic interneurons in the mouse medial prefrontal cortex. Nat Neurosci 2019; 22( 8): 1357– 1370

[150] Ährlund-Richter S, Xuan Y, van Lunteren JA, Kim H, Ortiz C, Pollak Dorocic I, Meletis K, Carlén M. A whole-brain atlas of monosynaptic input targeting four different cell types in the medial prefrontal cortex of the mouse. Nat Neurosci 2019; 22( 4): 657– 668

[151] Delgado MR, Beer JS, Fellows LK, Huettel SA, Platt ML, Quirk GJ, Schiller D. Viewpoints: Dialogues on the functional role of the ventromedial prefrontal cortex. Nat Neurosci 2016; 19( 12): 1545– 1552

[152] Dejean C, Courtin J, Rozeske RR, Bonnet MC, Dousset V, Michelet T, Herry C. Neuronal circuits for fear expression and recovery: recent advances and potential therapeutic strategies. Biol Psychiatry 2015; 78( 5): 298– 306

[153] Cho JH, Deisseroth K, Bolshakov VY. Synaptic encoding of fear extinction in mPFC-amygdala circuits. Neuron 2013; 80( 6): 1491– 1507

[154] Kulesskaya N, Voikar V. Assessment of mouse anxiety-like behavior in the light-dark box and open-field arena: role of equipment and procedure. Physiol Behav 2014; 133 : 30– 38

[155] Snyder CN, Brown AR, Buffalari D. Similar tests of anxiety-like behavior yield different results: comparison of the open field and free exploratory rodent procedures. Physiol Behav 2021; 230 : 113246

[156] Wiltschko AB, Tsukahara T, Zeine A, Anyoha R, Gillis WF, Markowitz JE, Peterson RE, Katon J, Johnson MJ, Datta SR. Revealing the structure of pharmacobehavioral space through motion sequencing. Nat Neurosci 2020; 23( 11): 1433– 1443

[157] von Ziegler L, Sturman O, Bohacek J. Big behavior: challenges and opportunities in a new era of deep behavior profiling. Neuropsychopharmacology 2021; 46( 1): 33– 44

[158] Liu N, Han Y, Ding H, Huang K, Wei P, Wang L. Objective and comprehensive re-evaluation of anxiety-like behaviors in mice using the Behavior Atlas. Biochem Biophys Res Commun 2021; 559 : 1– 7

RIGHTS & PERMISSIONS

Higher Education Press